Antibiotics/Respiratory Tract
50mg and 100mg · Veterinary Antibacterial Medicine · 10 Tablets per Blister · OEM/Private Label Available
Oral fluoroquinolone antibacterial tablets for the management of infections caused by bacteria susceptible to enrofloxacin in dogs and cats.
WERVIC supplies standard enrofloxacin tablets and supports veterinary medicine importers, distributors and animal health brands with customized strengths, packaging, multilingual labeling and product documentation.
Enrofloxacin Tablets for Susceptible Bacterial Infections
Enrofloxacin is a veterinary fluoroquinolone antibacterial agent. It acts against susceptible bacteria by inhibiting bacterial DNA gyrase, interfering with DNA replication and resulting in bactericidal activity.
Enrofloxacin tablets may be used in dogs and cats when a bacterial infection has been diagnosed and the pathogen is known or expected to be susceptible to enrofloxacin.
50mg enrofloxacin per tablet;
100mg enrofloxacin per tablet;
10 tablets per blister;
Oral administration;
For dogs and cats.
This is an antibacterial veterinary medicine, not an anti-inflammatory drug. It should not be used for viral, fungal or non-infectious inflammatory conditions.
The appropriate indication depends on the target species, bacterial susceptibility and locally approved product label.
Enrofloxacin tablets may be considered for susceptible bacterial infections involving:
Respiratory tract;
Urinary tract;
Skin and soft tissue;
Wounds and abscesses;
Selected gastrointestinal infections;
Other infections confirmed by veterinary diagnosis.
In cats, enrofloxacin may be used for diagnosed bacterial infections caused by susceptible organisms. Official product information includes feline dermal infections such as wounds and abscesses associated with susceptible bacteria.
Enrofloxacin should not be promoted as a universal treatment for every infection.
Susceptibility testing is recommended where practical, particularly when:
The infection is recurrent;
Previous antibacterial treatment has failed;
Resistant bacteria are suspected;
The animal has received repeated antibiotic courses;
The infection is severe or complicated;
Local antimicrobial guidelines restrict fluoroquinolone use.
A “susceptible” laboratory result indicates that the pathogen is likely to be inhibited by achievable drug concentrations. Resistant isolates are unlikely to respond adequately and require an alternative treatment.
| Parameter | Specification |
|---|---|
| Product Name | Enrofloxacin Tablets for Dogs and Cats |
| Active Ingredient | Enrofloxacin |
| Drug Class | Fluoroquinolone Antibacterial |
| Dosage Form | Oral Tablet |
| Available Strengths | 50 mg and 100 mg per tablet |
| Target Species | Dogs and Cats |
| Administration Route | Oral |
| Standard Packaging | 10 Tablets per Blister |
| Product Category | Prescription Veterinary Antibacterial Medicine* |
| Storage Conditions | Store according to the approved product specification. |
| Shelf Life | Subject to the final formulation and stability data. |
The 50mg strength may be more convenient for:
Cats, where permitted by the approved label;
Small and medium dogs;
Weight-based dose adjustment;
Markets preferring lower-strength blister products;
Veterinary clinics treating animals of different sizes.
The 100mg strength may be more suitable for:
Medium and large dogs;
Reducing the number of tablets per administration;
Clinic or distributor portfolios requiring a higher-strength option;
Markets where 100mg is an established registered strength.
For oral administration only.
The dose and treatment duration must follow:
The locally approved product label;
The prescribing veterinarian’s instructions;
Target species and body weight;
Infection type and severity;
Bacterial susceptibility;
Clinical response;
Applicable antimicrobial-use policies.
Fluoroquinolones are important veterinary antibacterial medicines. Improper or unnecessary use may contribute to bacterial resistance and reduce the effectiveness of future treatment.
Is intended for diagnosed or strongly suspected bacterial infections;
Should be used under veterinary direction;
Should not be used for routine prevention without an approved indication;
Should preferably be selected according to susceptibility testing;
Must be administered according to the approved dose and treatment duration;
Do not use in animals with known hypersensitivity to enrofloxacin or other quinolone-class medicines.
Important precautions include:
Use cautiously in animals with known or suspected central nervous system disorders;
Quinolones may be associated with CNS stimulation and seizures in susceptible animals;
Avoid use in immature dogs during rapid growth unless permitted by the approved label;
Fluoroquinolones have been associated with cartilage damage in growing animals;
Use cautiously in animals with impaired renal or hepatic function;
Do not exceed the approved daily dose in cats;
Safety in pregnant or breeding animals must be confirmed from the applicable product label;
Keep the medicine out of the reach of children and animals;
Use only for veterinary purposes.
Enrofloxacin use in cats has been associated with retinal toxicity in rare cases, particularly at excessive doses.
Possible adverse reactions may include:
Vomiting;
Reduced appetite;
Diarrhea or other gastrointestinal discomfort;
Depression or reduced activity;
Neurological signs in susceptible animals;
Retinal effects in cats when inappropriate doses are administered.
Drug Interaction Considerations
Products containing metal cations, including aluminum, calcium, iron and magnesium, may reduce the intestinal absorption of some quinolone medicines.
WERVIC supports enrofloxacin tablet projects for veterinary medicine importers, distributors, wholesalers and private label animal health brands.
Standard Product
The existing product configuration includes:
50mg tablets;
100mg tablets;
10 tablets per blister;
Packaging for dogs and cats.
| Customization Category | Available Options |
|---|---|
| Dosage Strength | Custom strengths available upon technical and regulatory evaluation |
| Tablet Design | Size, Shape, Color, Scored, Film Coating, Palatability |
| Dosage Form | Tablets (Standard), Capsules (OEM Project) |
| Packaging | Blister, Bottle, Carton, Insert, Export Carton |
| Branding | OEM, Private Label, Customer Logo, Multilingual Artwork |
| Regulatory Support | Subject to formulation validation, stability testing, and local registration requirements |
Product specification;
Certificate of Analysis for the supplied batch;
Qualitative and quantitative composition;
Manufacturing information;
Packaging specification;
Stability information;
GMP documentation;
Label and package insert;
Safety or technical data;
Registration-support documents.
What strengths of enrofloxacin tablets are available?
Standard strengths include 50mg and 100mg per tablet. Other strengths can be developed according to target-market registration requirements, animal weight ranges and order quantities.
Can the tablets be scored for easier dosing?
Yes. Scored tablets are available to support convenient tablet division and weight-based administration. The score design, tablet shape and division requirements can be customized according to the product specification.
Can you produce flavored enrofloxacin tablets?
Yes. Flavoring options can be added to improve palatability and make administration easier for dogs and cats. Flavor type and intensity can be adjusted during sample development.
Can the tablets be both flavored and scored?
Yes. Flavored and scored tablets can be produced in the same formulation, subject to confirmation of tablet size, hardness, stability and dosing requirements.
Do you offer enrofloxacin capsules?
Enrofloxacin capsules can be developed as an OEM or ODM product. The active strength, capsule size, shell material, filling formulation and packaging format should be confirmed before sample production.
What is the standard packaging?
The standard packaging is 10 tablets per blister. The number of blisters per carton can be adjusted according to the market and distribution channel.
Other options may include custom blister counts, printed aluminum foil, bottle packaging, retail cartons and multilingual package inserts.
Can I use my own brand and packaging?
Yes. Private label services include customer logos, product names, blister foil, cartons, labels, instructions, barcodes and batch-code formats.
Packaging content can be prepared in different languages according to the destination market.
What is the recommended storage condition?
Store the tablets in a cool, dry place below 25°C. Protect the product from moisture, direct sunlight and excessive heat, and keep it in the original sealed packaging until use.
The final storage statement should follow the approved product specification and registration requirements of the destination market.
What is the product shelf life?
The standard shelf life is generally 24 months when the product is stored under the recommended conditions.
The confirmed shelf life for each formulation, strength and packaging format should be based on the corresponding stability data.
Can you manufacture other tablet shapes or colors?
Yes. Tablet shape, size, color, coating and scoring can be customized according to brand positioning, dosing convenience and manufacturing feasibility.
What quality tests are performed?
Depending on the approved product specification, batch testing may include:
Enrofloxacin identification and assay;
Content uniformity;
Tablet weight variation;
Hardness and friability;
Disintegration or dissolution;
Related substances;
Moisture;
Appearance;
Packaging integrity.
A batch Certificate of Analysis can be supplied according to the agreed order and documentation requirements.
What documents can be provided?
Available documents may include:
Product specification;
Batch Certificate of Analysis;
Composition information;
Packaging specification;
Stability information;
GMP documentation;
Label and package insert files;
Registration-support documents.
What is the minimum order quantity?
MOQ depends on the strength, dosage form, flavor, tablet design and packaging requirements. Standard 50mg and 100mg products normally have different order conditions from newly developed strengths or capsule formulations.
Can samples be provided before mass production?
Yes. Samples can be arranged for standard tablets, flavored tablets, scored tablets or customized formulations. Customized samples may require additional formulation, tooling or packaging preparation.
